DR. ERIC KALDJIAN, M.D.
Medical Practice at Austin Ave, Ann Arbor, MI
License number
Michigan 4301054680
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
1912 Austin Ave, Ann Arbor, MI 48104
Phone
(734) 669-4404
Personal information
See more information about ERIC KALDJIAN at radaris.comName
Address
Phone
1912 Austin Ave, Ann Arbor, MI 48104
916 Grant St, Ypsilanti, MI 48197
Professional information
See more information about ERIC KALDJIAN at trustoria.com
Dr. Eric P Kaldjian, Ann Arbor MI - MD (Doctor of Medicine)
Dr. Eric P Kaldjian, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
1912 Austin Ave, Ann Arbor 48104
(734) 669-4404 (Phone), (734) 669-4404 (Fax)
(734) 669-4404 (Phone), (734) 669-4404 (Fax)
Certifications:
Anatomic Pathology, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Mi Med Sch
Graduated: 1989
University of Mi Med Sch
Graduated: 1989
Methods, Systems, And Kits For Evaluating Multiple Sclerosis
Methods, Systems, And Kits For Evaluating Multiple Sclerosis
US Patent:
2010020, Aug 19, 2010
Filed:
May 26, 2008
Appl. No.:
12/513764
Inventors:
Douglas Bigwood - Medison CT, US
Eric Eastman - Hihgland MD, US
Eric Kaldjian - Ann Arbor MI, US
Eric Eastman - Hihgland MD, US
Eric Kaldjian - Ann Arbor MI, US
Assignee:
ORE PHARMACEUTICALS , INC. - Gaithersburg MA
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention provides a method for evaluating multiple sclerosis (MS), or excluding MS as a diagnosis for a patient The method comprises determining a gene expression profile for a sample from such a patient. The gene expression profile, which contains gene expression values for a plurality of genes that are differentially expressed in white blood cells of MS patients, is compared to an MS-profile and/or a non-MS profile, and classified. The invention also provides a method for monitoring treatment of an MS patient Pre-treatment and post-treatment gene expression profiles contain gene expression values for a plurality of genes that are differentially expressed upon treatment of MS patients. The expression profiles may then be compared, to identify differences between pre-treatment and post-treatment gene expression. These differences are indicative of the patient's response to treatment The invention further provides kits and systems for performing the methods of the invention.